Diagnosis of Alzheimer's disease

Psychiatric Annals

Volumn 26, Issue 5, 1996, Pages 262-268

  Ashford, J Wesson ^a   Schmitt, Frederick A ^a   Kumar, Vinod ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042207624     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19960501-06     Document Type: Article

References (50)

1. Jarvik L, Greenson H. About a peculiar disease of the cerebral cortex, by Alois Alzheimer. Alzheimer Dis Assoc Disord. 1987; 1:7-8.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
3. McKhann C, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34:939-944.
4. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol. 1985; 42:1097-1105.
5. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991; 41:479-486.
6. Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part X: neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology. 1995; 45:461-466.
7. Roses AD. The Alzheimer diseases. Current Neurology. 1994; 14:111-141.
8. Sevush S, Leve N. Denial of memory deficit in Alzheimer's disease. Am J Psychiatry. 1993; 150:748-751.
9. Folstein MF, Folstein SE, McCugh PR. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198.
10. Ashford JW, Kolm P, Colliver JA, Bekian C, Hsu LN. Alzheimer patient evaluation and the Mini-Mental State: item characteristic curve analysis. J Gerontol. 1989; 5:139-146.
11. Fillenbaum GG, Wilkinson WE, Welsh KA, Mohs RC. Discrimination between stages of Alzheimer's disease with subsets of Mini-Mental State Examination items. Arch Neurol. 1994; 51:916-921.
12. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and education level. JAMA. 1993; 269:2386-2391.
13. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons. JAMA 1989; 262:2551-2556.
14. Stern RG, Mohs RC, Davidson M, et al. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry. 1994; 151:390-396.
15. Katzman R, Jackson JE. Alzheimer disease: basic and clinical advances. JAm Geriatr Soc. 1991; 39:516-525.
16. Schmitt FA, Sano MC. Neuropsychological approaches to the study of dementia. In: Morris JC, ed. Handbook of Dementing Illnesses. New York, NY: Marcel Dekker, Inc; 1994.
17. Welsh K, Butters N, Hughes J, Mohs R, Heyman A. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol. 1991; 48:278-281.
18. Petersen RC, Smith GE, Ivnik RJ, Kokmen E, Tangalos EG. Memory function in very early Alzheimer's disease. Neurology. 1994; 44:867-872.
19. Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology. 1994; 44:1427-1432.
20. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 1995; 273:1274-1278.
21. Siu AL. Screening for dementia and investigating its causes. Ann Intern Med. 1991; 115:122-132.
22. Eisdorfer C, Sevush S, Barry PB, Kumar V, Loewenstein DA. Evaluation of the demented patient. Med Clin North Am. 1994; 78:773-793.
23. Ashford JW, Kumar V, Barringer M, et al. Assessing Alzheimer severity with a global clinical scale. Int Psychogeriatr. 1992; 4:55-74.
24. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter in elderly subjects. Br J Psychiatry. 1968; 114:797-811.
25. Teresi J, Lawton MP, Ory M, Holmes D. Measurement issues in chronic care populations: dementia special care. Alzheimer Dis Assoc Disord. 1994; 8:S144-S183.
26. Holstein J, Chatellier G, Piette F, Moulias R. Prevalence of associated diseases in different types of dementia among elderly institutionalized patients: analysis of 3447 records. J Am Geriatric Soc. 1994; 42:972-977.
27. Clarfield AM. The reversible dementias: do they reverse? Ann Intern Med. 1988; 109:476-486.
28. Besdine RW, Brody JA, Butler RN, Duncan LE, Jarvik L, Libow L. Senility reconsidered: treatment possibilities for mental impairment in the elderly (Task Force Sponsored by the National Institute on Aging). JAMA. 1980; 244:259-263.
29. Galasko D, Hansen LA, Katzman R, et al. Clinical-neuropathological correlations in Alzheimer's disease and related disorders. Arch Neurol. 1994; 51:888-895.
30. Ashford JW, Rosenblatt MJ, Bekian C, Hayes T. The complete dementia evaluation: complications and complexities. American Journal of Alzheimer's Care and Research. 1985; 2:9-15.
31. Kent DL, Haynor DR, Longstreth WT, Larson EB. The clinical efficacy of magnetic resonance imaging in neuroimaging. Ann Intern Med. 1994; 120:856-871.
32. Erkinjuntti T, Gao F, Lee DH, Eliasziw M, Merskey H, Hachinski VC. Lack of difference in brain hyperintensities between patients with early Alzheimer's disease and control subjects. Arch Neurol. 1994; 51:260-268.
33. Jobst KA, Hindley NJ, King E, Smith AD. The diagnosis of Alzheimer's disease: a question of image? J Clin Psychiatry. 1994; 55(11, suppl):22-31.
34. Jagust WJ. Functional imaging in dementia: an overview. J Clin Psychiatry. 1994; 55(11, suppl):5-11.
35. Schmitt FA, Shih WJ, DeKosky ST. Neuropsychological correlates of single photon emission computed tomography (SPECT) in Alzheimer's disease. Neuropsychology. 1992; 6:159-171.
36. Small GW, Kuhl DE, Riege WH, et al. Cerebral glucose metabolic patterns in Alzheimer's disease: effect of gender and age at dementia onset. Arch Gen Psychiatry. 1989; 46:527-532.
37. 99mTc-Bicisate (Neurolite) SPECT brain imaging and cognitive impairment in dementia of the Alzheimer type: a blinded read of image sets from a multicenter SPECT trial. J Cereb Blood Flow Metab. 1994; 14:S99-S105.
38. Herholz K. FDG PET and differential diagnosis of dementia. Alzheimer Dis Assoc Disord. 1955; 9:6-16.
39. Stollberger R, Fazekas F, Payer F, Flooh E. Morphology-oriented analysis of cerebral SPECT using matched magnetic resonance images. Nucl Med Commun. 1995; 16:265-272.
40. Reisberg B, Ferris SH, de Leon MJ, Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982; 139:1136-1139.
41. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982; 140:566-572.
42. Reisberg B, Sclan SG, Franssen E, Kluger A, Ferris S. Dementia staging in chronic care populations. Alzheimer Dis Assoc Disord. 1994;8(suppl 1):S188-S205.
43. Ashford JW, Shan M, Butler S, Rajasekar A, Schmitt FA. Temporal quantification of Alzheimer's disease severity: 'Time-Index' model. Dementia. 1995; 6:269-280.
44. Cohen D, Eisdorfer C, Gorelick P, et al. Psychopathology associated with Alzheimer's disease and related disorders. J Gerontol. 1993; 48:M255-M260.
45. Oppenheim G. The earliest signs of Alzheimer's disease. J Geriatr Psychiatry Neurol. 1994; 7:118-122.
46. Reifler BV, Teri L, Raskind M, et al. Double-blind trial of imipramine in Alzheimer's disease patients with and without depression. Am J Psychiatry. 1989; 146:45-49.
47. Schneider LS, Pollock VE, Lyness SA. A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc. 1990; 38:553-563.
48. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993; 261:921-923.
49. Frisoni GB, Govoni S, Geroldi C, et al. Gene dose of the E4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol. 1995; 37:596-604.
50. Ohm TG, Muller H, Braak H, Bohl J. Close-meshed prevalence rates of different stage as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience. 1995; 64:209-217.